Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus

NCT02744898 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02744898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02744898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2016
Completion date
March 1, 2020
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer